Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells

DNA and Cell Biology

Volumn 24, Issue 4, 2005, Pages 244-255

  Roy, Sashwati ^a   Khanna, Savita ^a   Shah, Hiral ^a   Rink, Cameron ^a   Phillips, Christina ^a   Preuss, Harry ^b   Subbaraju, Gottumukkala V ^c   Trimurtulu, Golakoti ^c   Krishnaraju, Alluri V ^c   Bagchi, Manashi ^d   Bagchi, Debasis ^d   Sen, Chandan K ^a,e  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Laila Impex R and D Centre   (India)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 LOXIN; BOSWELLIA EXTRACT; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; IBUPROFEN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; MATRIX METALLOPROTEINASE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BOSWELLIA; BOSWELLIA SERRATA; CELL ADHESION; CHRONIC INFLAMMATION; ENDOTHELIUM CELL; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN GENOME; INFLAMMATION; MICROVASCULATURE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BOSWELLIA; CARRAGEENAN; DNA PRIMERS; EDEMA; ENDOTHELIAL CELLS; FOOT; GENE EXPRESSION REGULATION; GENES; GENOME, HUMAN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOTRIENES; MATRIX METALLOPROTEINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLANT EXTRACTS; PLETHYSMOGRAPHY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA; BOSWELLIA; BOSWELLIA SERRATA; BURSERACEAE;

EID: 20144389476     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.244     Document Type: Article

References (73)

1. ALTMANN, A., FISCHER, L., SCHUBERT-ZSILAVECZ, M., STEINHILBER, D., and WERZ, O. (2002). Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization. Biochem. Biophys. Res. Commun. 290, 185-190.
2. AMMON, H.P. (1996). Salai Guggal-Boswellia serrata: From a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis. Eur. J. Med. Res. 1, 369-370.
3. AMMON, H.P. (2002). Boswelliasauren (Inhaltsstoffe des Weihrauchs) als wirksame Prinzipien zur Behandlung chronisch entzundlicher Erkrankungen. Wien. Med. Wochenschr. 152, 373-378.
4. AMMON, H.P., MACK, T., SINGH, G.B., and SAFAYHI, H. (1991). Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med. 57, 203-207.
5. AMMON, H.P., SAFAYHI, H., MACK, T., and SABIERAJ, J. (1993). Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 38, 113-119.
6. BENT, S., and KO, R. (2004). Commonly used herbal medicines in the United States: A review. Am. J. Med. 116, 478-485.
7. BODEN, S.E., SCHWEIZER, S., BERTSCHE, T., DUFER, M., DREWS, G., and SAFAYHI, H. (2001). Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid. Mol. Pharmacol. 60, 267-273.
8. BORCHERS, A.T., KEEN, C.L., STERN, J.S., and GERSHWIN, M.E. (2000). Inflammation and Native American medicine: The role of botanicals. Am. J. Clin. Nutr. 72, 339-347.
9. CALIXTO, J.B., CAMPOS, M.M., OTUKI, M.F., and SANTOS, A.R. (2004). Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 70, 93-103.
10. CECCHI, R., RUSCONI, L., TANZI, M.C., DANUSSO, F., and FERRUTI, P. (1981). Synthesis and pharmacological evaluation of poly(oxyethylene) derivatives of 4-isobutylphenyl-2-propionic acid (ibuprofen). J. Med. Chem. 24, 622-625.
11. CHAINANI-WU, N. (2003). Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement. Med. 9, 161-168.
12. CHOY, E.H., and PANAYI, G.S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. New Engl. J. Med. 344, 907-916.
13. CHURG, A., WANG, R.D., TAI, H., WANG, X., XIE, C., DAI, J., SHAPIRO, S.D., and WRIGHT, J.L. (2003). Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release [see comment]. Am. J. Respirat. Crit. Care Med. 167, 1083-1089.
14. COHEN, S.M., ROUSSEAU, M.E., and ROBINSON, E.H. (2000). Therapeutic use of selected herbs. Holist. Nurs. Pract. 14, 59-68.
15. COLTEN, H.R., and KRAUSE, J.E. (1997). Pulmonary inflammation - A balancing act. New Engl. J. Med. 336, 1094-1096.
16. CUZZOCREA, S., ROSSI, A., SERRAINO, I., MAZZON, E., DI PAOLA, R., DUGO, L., GENOVESE, T., CALABRO, B., CAPUTI, A.P., and SAUTEBIN, L. (2003). 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan. J. Leukoc. Biol. 73, 739-746.
17. DAHLQUIST, K.D., SALOMONIS, N., VRANIZAN, K., LAWLOR, S.C., and CONKLIN, B.R. (2002). GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31, 19-20.
18. DANESH, J., WHEELER, J.G., HIRSCHFIELD, G.M., EDA, S., EIRIKSDOITIR, G., RUMLEY, A., LOWE, G.D., PEPYS, M.B., and GUDNASON, V. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [see comment]. New Engl. J. Med. 350, 1387-1397.
19. DAXECKER, H., RAAB, M., MARKOVIC, S., KARIMI, A., GRIESMACHER, A., and MUELLER, M.M. (2002). Endothelial adhesion molecule expression in an in vitro model of inflammation. Clin. Chim. Acta 325, 171-175.
20. DE CATERINA, R., and ZAMPOLLI, A. (2004). From asthma to atherosclerosis-5-Lipoxygenase, leukotrienes, and inflammation [comment]. New Engl. J. Med. 350, 4-7.
21. DENNIS, G., JR., SHERMAN, B.T., HOSACK, D.A., YANG, J., GAO, W., LANE, H.C., and LEMPICKI, R.A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3.
22. DUWIEJUA, M., ZEITLIN, I.J., WATERMAN, P.G., CHAPMAN, J., MHANGO, G.J., and PROVAN, G.J. (1993). Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Planta Med. 59, 12-16.
23. EL-KHADEM, H., EL-SHAFEI, Z.M., EL-SEKEILY, M.A., and RAHMAN, M.M. (1972). Derivatives of boswellic acids. Planta Med. 22, 157-159.
24. ERNST, E., and CHRUBASIK, S. (2000). Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. Rheum. Dis. Clin. North Am. 26, 13-27.
25. FELDMANN, M., and MAINI, R.N. (2001). Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu. Rev. Immunol. 19, 163-196.
26. FELDMANN, M., BRENNAN, P.M., PALEOLOG, E., COPE, A., TAYLOR, P., WILLIAMS, R., WOODY, J., and MAINI, R.N. (2004). Anti-TNFalpha therapy of rheumatoid arthritis: What can we learn about chronic disease? Novartis Found. Symp. 256, 53-69; discussion 69-73.
27. FISCHER, L., SZELLAS, D., RADMARK, O., STEINHILBER, D., and WERZ, O. (2003). Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors. FASEB J. 17, 949-951.
28. GOMEZ, M.I., LEE, A., REDDY, B., MUIR, A., SOONG, G., PITT, A., CHEUNG, A., and PRINCE, A. (2004). Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. EPub July 11.
29. GUAY, J., BATEMAN, K., GORDON, R., MANCINI, J., and RIENDEAU, D. (2004). Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J. Biol. Chem. 279, 24866-24872.
30. GUPTA, I., GUPTA, V., PARIHAR, A., GUPTA, S., LUDTKE, R., SAFAYHI, H., and AMMON, H.P. (1998). Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 3, 511-514.
31. GUPTA, I., PARIHAR, A., MALHOTRA, P., GUPTA, S., LUDTKE, R., SAFAYHI, H., and AMMON, H.P. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 67, 391-395.
32. KAPLAN, M. (2002). Eculizumab (Alexion). Curr. Opin. Invest. Drugs 3, 1017-1023.
33. KIMMATKAR, N., THAWANI, V., HINGORANI, L., and KHIYANI, R. (2003). Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - A randomized double blind placebo controlled trial. Phytomedicine 10, 3-7.
34. KRIEGLSTEIN, C.F., ANTHONI, C., RUCKEN, E.J., LAUKOTTER, M., SPIEGEL, H.U., BODEN, S.E., SCHWEIZER, S., SAFAYHI, H., SENNINGER, N. and SCHURMANN, G. (2001). Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int. J. Color. Dis. 16, 88-95.
35. KUEHL, F.A., JR., and EGAN, R.W. (1980). Prostaglandins, arachidonic acid, and inflammation. Science 210, 978-984.
36. KUMAGAI, K., OHNO, I., IMAI, K., NAWATA, J., HAYASHI, K., OKADA, S., SENOO, H., HATTORI, T., and SHIRATO, K. (2002). The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation. Clin. Exp. Allergy 32, 1527-1534.
37. LANONE, S., ZHENG, T., ZHU, Z., LIU, W., LEE, C.G., MA, B., CHEN, Q., HOMER, R.J., WANG, J., RABACH, L.A., et al. (2002). Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110, 463-474.
38. LI, C., and WONG, W.H. (2001). Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98, 31-36.
39. LINDAHL, B., TOSS, H., SIEGBAHN, A., VENGE, P., and WALLENTIN, L. (2000). Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease [see comment]. New Engl. J. Med. 343, 1139-1147.
40. LONG, L., SOEKEN, K., and ERNST, E. (2001). Herbal medicines for the treatment of osteoarthritis: A systematic review [see comment]. Rheumatology 40, 779-793.
41. LUSTER, A.D. (1998). Chemokines-Chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338, 436-445.
42. MAGNANI, M., CRINELLI, R., BIANCHI, M., and ANTONELLI, A. (2000). The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr. Drug Targets 1, 387-399.
43. MASON, J.C., YARWOOD, H., SUGARS, K.B., MORGAN, P., DAVIES, K.A., and HASKARD, D.O. (1999). Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood 94, 1673-1682.
44. MORIN, L, LI, W.Q., SU, S., AHMAD, M., and ZAFARULLAH, M. (1999). Induction of stromelysin gene expression by tumor necrosis factor alpha is inhibited by dexamethasone, salicylate, and N-acetyl-cysteine in synovial fibroblasts. J. Pharmacol. Exp. Ther. 289, 1634-1640.
45. MORRIS, C.J. (2003). Carrageenan-induced paw edema in the rat and mouse. Methods Mol. Biol. 225, 115-121.
46. NATHAN, C. (2002). Points of control in inflammation. Nature 420, 846-852.
47. PARK, Y.S., LEE, J.H., HARWALKAR, J.A., BONDAR, J., SAFAYHI, H., and GOLUBIC, M. (2002). Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. Adv. Exp. Med. Biol. 507, 387-393.
48. PHILLIPSON, J.D. (2003). 50 years of medicinal plant research - Every progress in methodology is a progress in science. Planta Med. 69, 491-495.
49. POBER, J.S. (2002). Endothelial activation: Untracellular signaling pathways. Arthritis Res. 4(Suppl 3), S109-S116.
50. POSADAS, I., BUCCI, M., ROVIEZZO, F., ROSSI, A., PARENTE, L., SAUTEBIN, L., and CIRINO, G. (2004). Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br. J. Pharmacol. 142, 331-338.
51. REICHLING, J., SCHMOKEL, H., FITZI, J., BUCHER, S., and SALLER, R. (2004). Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweizer Arch. Tierheil. 146, 71-79.
52. RIJCKEN, E., KRIEGLSTEIN, C.F., ANTHONI, C., LAUKOETTER, M.G., MENNIGEN, R., SPIEGEL, H.U., SENNINGER, N., BENNETT, C.F., and SCHUERMANN, G. (2002). ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease. Gut 51, 529-535.
53. ROY, S., KHANNA, S., BENTLEY, K., BEFFREY, P., and SEN, C.K. (2002a). Functional genomics: High-density oligonucleotide arrays. In: Methods in Enzymology (Elsevier, St. Louis, MO) pp. 487-497.
54. ROY, S., LADO, B.H., KHANNA, S., and SEN, C.K. (2002b). Vitamin E sensitive genes in the developing rat fetal brain: A high-density oligonucleotide microarray analysis. FEBS Lett. 530, 17-23.
55. ROY, S., KHANNA, S., WALLACE, W.A., LAPPALAINEN, J., RINK, C., CARDOUNEL, A.J., ZWEIER, J.L., and SEN, C.K. (2003). Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J. Biol. Chem. 278, 47129-47135.
56. SAFAYHI, H., MACK, T., SABIERAJ, J., ANAZODO, M.I., SUBRAMANIAN, L.R., and AMMON, H.P. (1992). Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261, 1143-1146.
57. SAFAYHI, H., RALL, B., SAILER, E.R., and AMMON, H.P. (1997). Inhibition by boswellic acids of human leukocyte elastase. J. Pharmacol. Exp. Ther. 281, 460-463.
58. SAFAYHI, H., BODEN, S.E., SCHWEIZER, S., and AMMON, H.P. (2000). Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med. 66, 110-113.
59. SAILER, E.R., SCHWEIZER, S., BODEN, S.E., AMMON, H.P., and SAFAYHI, H. (1998). Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling. Eur. J. Biochem. 256, 364-368.
60. SCHWEIZER, S., VON BROCKE, A.F., BODEN, S.E., BAYER, E., AMMON, H.P., and SAFAYHI, H. (2000). Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues. J. Natural Products 63, 1058-1061.
61. SHARMA, S., THAWANI, V., HINGORANI, L., SHRIVASTAVA, M., BHATE, V.R., and KHIYANI, R. (2004). Pharmacokinetic study of 11-Keto beta-Boswellic acid. Phytomedicine 11, 255-260.
62. STRIETER, R.M., KUNKEL, S.L., and BONE, R.C. (1993). Role of tumor necrosis factor-alpha in disease states and inflammation. Crit. Care Med. 21, S447-S463.
63. SULLIVAN, K.E. (2003). Regulation of inflammation. Immunol. Res. 27, 529-538.
64. SWERLICK, R.A., and LAWLEY, T.J. (1993). Role of microvascular endothelial cells in inflammation. J. Invest. Dermatol. 100, 111S-115S.
65. VALLE, E., GROSS, M., and BICKSTON, S.J. (2001). Infliximab. Expert Opin. Pharmacother. 2, 1015-1025.
66. VARELA, L.M., STANGLE-CASTOR, N.C., SHOEMAKER, S.F., SHEA-BATON, W.K., and IP, M.M. (2001). TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J. Cell. Physiol. 188, 120-131.
67. WAGNER, R., MYERS, R.R., and O'BRIEN, J.S. (1998). Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-alpha nerve injection. Neuroreport 9, 2827-2831.
68. WARNER, R.L., BHAGAVATHULA, N., NERUSU, K.C., LATEEF, H., YOUNKIN, E., JOHNSON, K.J., and VARANI, J. (2004). Matrix metalloproteinases in acute inflammation: Induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp. Mol. Pathol. 76, 189-195.
69. WARREN, J.S., WARD, P.A., and JOHNSON, K.J. (1988). Tumor necrosis factor: A plurifunctional mediator of acute inflammation. Modern Pathol. 1, 242-247.
70. WARTENBERG, M., BUDDE, P., DE MAREES, M., GRUNHECK, F., TSANG, S.Y., HUANG, Y., CHEN, Z.Y., HESCHELER, J., and SAUER, H. (2003). Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab. Invest. 83, 87-98.
71. WERZ, O., SZELLAS, D., HENSELER, M., and STEINHILBER, D. (1998). Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity. Mol. Pharmacol. 54, 445-451.
72. WILDFEUER, A., NEU, I.S., SAFAYHI, H., METZGER, G., WEHRMANN, M., VOGEL, U., and AMMON, H.P. (1998). Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung 48, 668-674.
73. WOLF, D., HALLMANN, R., SASS, G., SIXT, M., KUSTERS, S., FREGIEN, B., TRAUTWEIN, C., and TIEGS, G. (2001). TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-Relevance for concanavalin A-induced hepatitis. J. Immunol. 166, 1300-1307.